Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (PDF, 156KB)
Why become a member?

Painful Intercourse In Women Improved With Fibromyalgia Drug, Rutgers Study Says

Friday 4 January 2019

 

From Rutgers University's Rutgers Today:

 

Gloria Bachmann
Gloria Bachmann was the lead author in this study,
which was the first to analyze sexual function in
women with vulva pain treated with Gabapentin.
(Photo by John O'Boyle)
 

Painful Intercourse in Women Improved with Fibromyalgia Drug, Rutgers Study Says

Study suggests that the oral medication Gabapentin can reduce pain and increase sexual desire and satisfaction

By Patti Verbanas
Thursday January 3, 2019
Copyright ©2019, Rutgers, The State University of New Jersey. All rights reserved.

Women with chronic pain or discomfort around the vulva showed improved sexual function with an oral nerve pain medication used to treat pain caused by a previous Herpes infection as well as fibromyalgia, according to a Rutgers study.

The study, which was the first to analyze sexual function in women with vulva pain treated with Gabapentin, appeared in the American Journal of Obstetrics and Gynecology.

The women in the study were diagnosed with provoked vulvodynia, a chronic pain syndrome that is characterized by symptoms such as stinging, burning, irritation or itching at the entry to the vagina. The pain usually occurs with contact, such as from tampon insertion or intercourse, which can lead to sexual dysfunction.

“Previous studies have suggested Gabapentin reduces the pain of fibromyalgia, a chronic condition that includes widespread pain in various parts of the body. Our theory was that reducing pelvic floor muscle pain might reduce vulvodynia pain overall and thus improve sexual function,” said lead author Gloria Bachmann, director of the Women’s Health Institute at Rutgers Robert Wood Johnson Medical School.

The researchers found that the 230 women studied, who had an average age of 37 and, for most, had the condition for more than five years, experienced less pain and improved sexual desire, arousal and satisfaction after using the oral medication. However, their overall sexual function remained lower than women without this pain disorder.

“We found that women with greater muscle pain responded better in terms of pain and improved arousal than those with less pain, which suggests that Gabapentin be considered for treatment in women who have significant muscle tightness and spasm in the pelvic region,” said Bachmann.

 

Full article…

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page